Literature DB >> 20819889

Rosiglitazone: what went wrong?

Deborah Cohen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819889     DOI: 10.1136/bmj.c4848

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  32 in total

1.  Rosiglitazone: a European regulatory perspective.

Authors:  E Blind; K Dunder; P A de Graeff; E Abadie
Journal:  Diabetologia       Date:  2010-12-14       Impact factor: 10.122

2.  Rosiglitazone: trials, tribulations and termination.

Authors:  Andrew J Krentz
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 3.  Today's challenges in pharmacovigilance: what can we learn from epoetins?

Authors:  Hans C Ebbers; Aukje K Mantel-Teeuwisse; Ellen H M Moors; Huub Schellekens; Hubert G Leufkens
Journal:  Drug Saf       Date:  2011-04-01       Impact factor: 5.606

4.  Challenges of translating basic research into therapeutics: resveratrol as an example.

Authors:  James M Smoliga; Ole Vang; Joseph A Baur
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-11       Impact factor: 6.053

5.  How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?

Authors:  Jason C Hsu; Dennis Ross-Degnan; Anita K Wagner; Fang Zhang; Christine Y Lu
Journal:  Clin Ther       Date:  2015-05-11       Impact factor: 3.393

6.  Risk Communication and the Pharmaceutical Industry: what is the reality?

Authors:  Brian Edwards; Sweta Chakraborty
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

7.  All health researchers should begin their training by preparing at least one systematic review.

Authors:  Kamal R Mahtani
Journal:  J R Soc Med       Date:  2016-04-26       Impact factor: 5.344

8.  The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Barbara Mintzes
Journal:  Int J Health Policy Manag       Date:  2016-02-18

9.  Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.

Authors:  Aditi Jain; Vibha Rani
Journal:  Mol Cell Biochem       Date:  2017-09-19       Impact factor: 3.396

Review 10.  Oxidative stress and protein carbonylation in adipose tissue - implications for insulin resistance and diabetes mellitus.

Authors:  Tatjana Ruskovska; David A Bernlohr
Journal:  J Proteomics       Date:  2013-04-11       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.